Katelyn W Sylvester

9PUBLICATIONS
14CO-AUTHORS
HaematologyGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsRespiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 13, 2026
Evaluation of anticoagulation management in patients with suspected heparin-induced thrombocytopenia awaiting diagnosis confirmation.

|Dec 11, 2025
Real World Experience with use of Coagulation Factor VIIa at an Academic Medical Center.

Alyssa R George, Katelyn W Sylvester, Dareen M Kanaan

|May 11, 2022
Optimization of DOAC management services in a centralized anticoagulation clinic.

Katelyn W Sylvester, Alisia Chen, Andrea Lewin

|Aug 13, 2021
Heparin-induced thrombocytopenia in end-stage renal disease: Reliability of the PF4-heparin ELISA.

Julie Kelly, Katelyn W Sylvester, Jessica Rimsans

|May 20, 2021
Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study.

Lachelle D Weeks, Katelyn W Sylvester, Jean M Connors

|Aug 02, 2020
Evaluation of oral factor Xa inhibitor-associated extracranial bleeding reversal with andexanet alfa.

Charlie J Nederpelt, Leon Naar, Katelyn W Sylvester

Pageof 2

Frequent Collaborators

7 joint publications

Jean M Connors

2 joint publications

Nathan T Connell

2 joint publications

Alyssa R George

2 joint publications

Dareen M Kanaan